These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25114522)

  • 1. Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy.
    Liu L; Liu X; Xu Q; Wu P; Zuo X; Zhang J; Deng H; Wu Z; Ji A
    Int J Nanomedicine; 2014; 9():3509-26. PubMed ID: 25114522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.
    Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A
    Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles.
    Yamamoto S; Kato A; Sakurai Y; Hada T; Harashima H
    J Control Release; 2017 Apr; 251():1-10. PubMed ID: 28192155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts.
    Liao L; Cen B; Li G; Wei Y; Wang Z; Huang W; He S; Yuan Y; Ji A
    Drug Deliv; 2021 Dec; 28(1):1432-1442. PubMed ID: 34236267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
    Yang H; Che O; Chen S; Sun L; Ji AM
    Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of VEGF-siRNA/CRS as a novel vector for gene delivery.
    Zhao W; Zhang Y; Jiang X; Cui C
    Drug Des Devel Ther; 2016; 10():3851-3865. PubMed ID: 27920500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts.
    Chen S; Liu X; Gong W; Yang H; Luo D; Zuo X; Li W; Wu P; Liu L; Xu Q; Ji A
    Oncol Rep; 2013 Jan; 29(1):260-8. PubMed ID: 23117577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy.
    Dong Y; Yu T; Ding L; Laurini E; Huang Y; Zhang M; Weng Y; Lin S; Chen P; Marson D; Jiang Y; Giorgio S; Pricl S; Liu X; Rocchi P; Peng L
    J Am Chem Soc; 2018 Nov; 140(47):16264-16274. PubMed ID: 30346764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.
    Zhao Z; Li Y; Shukla R; Liu H; Jain A; Barve A; Cheng K
    Theranostics; 2019; 9(15):4508-4524. PubMed ID: 31285776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
    Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
    Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted gene silencing using RGD-labeled chitosan nanoparticles.
    Han HD; Mangala LS; Lee JW; Shahzad MM; Kim HS; Shen D; Nam EJ; Mora EM; Stone RL; Lu C; Lee SJ; Roh JW; Nick AM; Lopez-Berestein G; Sood AK
    Clin Cancer Res; 2010 Aug; 16(15):3910-22. PubMed ID: 20538762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery.
    Wang Y; Chen S; Yang X; Zhang S; Cui C
    Drug Des Devel Ther; 2021; 15():1531-1547. PubMed ID: 33883877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo.
    Xia Y; Tang G; Guo M; Xu T; Chen H; Lin Z; Li Y; Chen Y; Zhu B; Liu H; Cao J
    Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110594. PubMed ID: 32204058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.
    Shen M; Gong F; Pang P; Zhu K; Meng X; Wu C; Wang J; Shan H; Shuai X
    Int J Nanomedicine; 2012; 7():3319-32. PubMed ID: 22802690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.